Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
Nimotuzumab has a humanized human-mouse h-R3 heavy chain and a humanized human-mouse h-R3κ-chain. nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division.
Nimotumab is supplied at a concentration of 5 mg/mL as a sterile, clear and colorless, preservative-free liquid, which contains 0.45 mg/mL dibasic sodium phosphate, dihydrate, 1.8 mg/mL monobasic sodium phosphate, 0.2 mg /mL polysorbate 80, 8.6 mg/mL Sodium chloride and Water for Injection.
Properties
Name | Nimotuzumab |
CAS NO. | 828933-51-3/780758-10-3 |
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | EGFR |
Clone | Monoclone |
Molecular Weight | 148 kDa |
Formula | C6566H10082N1746O2056S40 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Nimotuzumab
